Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China · Delayed Price · Currency is CNY 7.42
+0.11 (1.50%)
Jul 31, 2026, 3:00 PM CST
SHA:603229 Market Cap
SHA:603229 has a market cap or net worth of 6.12 billion as of July 31, 2026. Its market cap has decreased by -29.94% in one year.
Market Cap
6.12B
Enterprise Value
5.45B
Revenue
794.80M
Ranking
n/a
PE Ratio
55.26
Stock Price
7.42
ChartMarket Cap Chart
Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 6.12B, an increase of 240.12%. That is a compound annual growth rate of 14.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 6.12B | -25.49% |
| Dec 31, 2025 | 8.22B | -0.94% |
| Dec 31, 2024 | 8.29B | 5.87% |
| Dec 29, 2023 | 7.83B | -18.09% |
| Dec 30, 2022 | 9.56B | -8.49% |
| Dec 31, 2021 | 10.45B | 19.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovita Biological Technology | 7.71B |
| Daan Gene | 7.65B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 7.59B |
| Bio-Thera Solutions | 7.08B |
| Shanghai OPM Biosciences | 6.88B |
| Wuhan Keqian Biology Co.,Ltd | 6.04B |
| Chengdu Kanghua Biological Products | 6.01B |
| Jiangsu Aidea Pharmaceutical Group | 5.82B |